Copyright
©The Author(s) 2025.
World J Hepatol. Jul 27, 2025; 17(7): 108850
Published online Jul 27, 2025. doi: 10.4254/wjh.v17.i7.108850
Published online Jul 27, 2025. doi: 10.4254/wjh.v17.i7.108850
Figure 2 Comparison of serum biomarker levels among study groups assessed by Kruskal-Wallis test.
A: The level of serum extra spindle pole bodies-like 1 (ESPL1) protein; B: The level of serum p53 antibody. ESPL1: Extra spindle pole bodies-like 1 CHB: Chronic hepatitis B; HBV-LC: Hepatitis B virus-related liver cirrhosis; HBV-HCC: Hepatitis B virus-related hepatocellular carcinoma; ns: Not significant.
- Citation: Feng YF, Zhou HK, Hu BB, Wang H, Liang HK, Wei L, Li QM, Su TM, Yin QB, Su MH, Jiang JN. Evaluating serum extra spindle pole bodies-like 1 protein vs p53 antibody for hepatitis B virus-related hepatocellular carcinoma diagnosis. World J Hepatol 2025; 17(7): 108850
- URL: https://www.wjgnet.com/1948-5182/full/v17/i7/108850.htm
- DOI: https://dx.doi.org/10.4254/wjh.v17.i7.108850